申请人:Janssen Pharmaceutica N.V.
                            
                            
                                公开号:US04219559A1
                            
                            
                                公开(公告)日:1980-08-26
                            
                            Novel N-heterocyclyl-4-piperidinamines wherein said heterocyclic radical is an optionally substituted 1H-benzimidazol-2-yl or 3H-imidazo[4,5-b]pyridin-2-yl radical, said compounds being useful as antihistaminic agents.
                            这句话的中文翻译是:新型N-杂环基-4-
哌啶胺,其中所述的杂环基是可选取代的1H-
苯并咪唑-2-基或3H-
咪唑并[4,5-b]
吡啶-2-基,这些化合物可用作
抗组胺药物。